Cargando…

Preferences for oral versus intravenous adjuvant chemotherapy among early breast cancer patients

PURPOSE: The purpose of this study was to evaluate preferences for oral versus intravenous adjuvant chemotherapy among early breast cancer patients (UMIN-CTR number UMIN000004696). PATIENTS AND METHODS: Eighty-two postmenopausal women with estrogen receptor-positive, human epidermal growth-factor re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ishitobi, Makoto, Shibuya, Kazuyo, Komoike, Yoshifumi, Koyama, Hiroki, Inaji, Hideo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2013
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3839808/ https://www.ncbi.nlm.nih.gov/pubmed/24293991 http://dx.doi.org/10.2147/PPA.S52687

Ejemplares similares

Evaluation of ALDH1 expression in ipsilateral breast cancer recurrence
por: Shien, Tadahiko, et al.
Publicado: (2017)

Distant recurrence risk following early ipsilateral breast tumor recurrence
por: Ishitobi, Makoto, et al.
Publicado: (2017)

Influence of Tamoxifen‐Medroxyprogesterone Sequential Therapy on Estrogen and Progesterone Receptor Contents of Breast Cancer
por: Noguchi, Shinzaburo, et al.
Publicado: (1989)

Patients' preferences for adjuvant chemotherapy in early-stage breast cancer: is treatment worthwhile?
por: Jansen, S J T, et al.
Publicado: (2001)

Prognostic Significance of Occult Bone Marrow Micrometastases of Breast Cancer Detected by Quantitative Polymerase Chain Reaction for Cytokeratin 19 mRNA
por: Ikeda, Noriko, et al.
Publicado: (2000)

O(6)-methylguanine-DNA methyltransferase as a prognostic and predictive marker for basal-like breast cancer treated with cyclophosphamide-based chemotherapy
por: ISONO, SAYURI, et al.
Publicado: (2014)

Changes in Hematologic Parameters during Treatment with Medroxyprogesterone Acetate for Breast Cancer
por: Yamamoto, Hitoshi, et al.
Publicado: (1991)

Oral uracil–tegafur compared with intravenous chemotherapy as adjuvant therapy for resected early‐stage non‐small cell lung cancer patients
por: Liang, Sheng‐Kai, et al.
Publicado: (2023)

Lentinula edodes mycelia extract plus adjuvant chemotherapy for breast cancer patients: Results of a randomized study on host quality of life and immune function improvement
por: Nagashima, Yukiko, et al.
Publicado: (2017)

Adjuvant chemotherapy for early breast cancer.
por: Henderson, I. C.
Publicado: (1990)

Early versus late distant metastasis and adjuvant chemotherapy alone versus both radiotherapy and chemotherapy in molecular apocrine breast cancer
por: Liu, Xiaozhen, et al.
Publicado: (2016)

Steroid treatment increases the recurrence of radiation-induced organizing pneumonia after breast-conserving therapy
por: Otani, Keisuke, et al.
Publicado: (2014)

Patient-reported preferences for oral versus intravenous administration for the treatment of cancer: a review of the literature
por: Eek, Daniel, et al.
Publicado: (2016)

Inhibitory Effect of a Somatostatin Analogue (SMS 201–995) on the Growth of Androgen‐dependent Mouse Mammary Tumor (Shionogi Carcinoma 115)
por: Noguchi, Shinzaburo, et al.
Publicado: (1993)

Update on Adjuvant Chemotherapy for Early Breast Cancer
por: Rampurwala, Murtuza M, et al.
Publicado: (2014)

Regression of brain metastases from breast cancer with eribulin: a case report
por: Matsuoka, Hiromichi, et al.
Publicado: (2013)

Surgical therapy for pulmonary metastasis of breast cancer
por: Soh, Junichi, et al.
Publicado: (2020)

Changes in eating habits and food preferences in breast cancer patients undergoing adjuvant chemotherapy
por: Pedersini, Rebecca, et al.
Publicado: (2021)

1927. Preference for Intravenous vs. Oral Antibiotics at Hospital Discharge
por: Karabanow, Anthony, et al.
Publicado: (2018)

Efficacy, Toxicity, and Pharmacokinetics of Intra-Arterial Chemotherapy Versus Intravenous Chemotherapy for Retinoblastoma in Animal Models and Patients
por: Daniels, Anthony B., et al.
Publicado: (2021)

Concurrent chemoradiotherapy with intravenous cisplatin and docetaxel for advanced oral cancer
por: Sato, Kotaro, et al.
Publicado: (2019)

Oral vinorelbine versus intravenous vinorelbine, in combination with epirubicin as first-line chemotherapy in Chinese patients with metastatic breast cancer
por: Huang, Liang, et al.
Publicado: (2019)

Adjuvant chemotherapy for early-stage cervical cancer
por: Asano, Hiroshi, et al.
Publicado: (2016)

The impact of early adjuvant chemotherapy in rectal cancer
por: Noh, Gyoung Tae, et al.
Publicado: (2020)

Is adjuvant chemotherapy necessary for early gastric cancer?
por: Mei, Yu, et al.
Publicado: (2022)

Patients’ Preferences for 3 Months vs 6 Months of Adjuvant Chemotherapy for Colon Cancer
por: Blinman, Prunella, et al.
Publicado: (2020)

Phase II feasibility study of adjuvant chemotherapy with docetaxel/cisplatin/S-1 followed by S-1 for stage III gastric cancer
por: Hirahara, Noriyuki, et al.
Publicado: (2021)

Usefulness of dexmedetomidine as an intravenous adjuvant
por: Parthasarathy, S.
Publicado: (2020)

Precision medicine for adjuvant chemotherapy of resected colorectal cancer
por: Miyamoto, Yuji, et al.
Publicado: (2020)

Neoadjuvant intra-arterial versus intravenous chemotherapy in colorectal cancer
por: Peng, Shu hui, et al.
Publicado: (2021)

Adjuvant Bidirectional Chemotherapy with Intraperitoneal Pemetrexed Combined with Intravenous Cisplatin for Diffuse Malignant Peritoneal Mesothelioma
por: Bijelic, Lana, et al.
Publicado: (2012)

Preference of elderly patients’ to oral or intravenous chemotherapy in heavily pre-treated recurrent ovarian cancer: final results of a prospective multicenter trial
por: Chekerov, Radoslav, et al.
Publicado: (2017)

An Unsupported Preference for Intravenous Antibiotics
por: Li, Ho Kwong, et al.
Publicado: (2015)

Patients' preferences for adjuvant endocrine therapy in early breast cancer: what makes it worthwhile?
por: Duric, V M, et al.
Publicado: (2005)

Uracil-tegafur and tamoxifen versus cyclophosphamide, methotrexate, fluorouracil, and tamoxifen in postoperative adjuvant therapy for stage I, II, or IIIA lymph node-positive breast cancer: a comparative study
por: Park, Y, et al.
Publicado: (2009)

Body weight loss after surgery affects the continuity of adjuvant chemotherapy for pancreatic cancer
por: Morita, Yoshifumi, et al.
Publicado: (2019)

Breast cancer local recurrence after mastectomy with immediate latissimus dorsi myocutaneous flap reconstruction: A case report
por: Shinzaki, Wataru, et al.
Publicado: (2023)

Evaluation of the exposure equivalence of oral versus intravenous temozolomide
por: Diez, Blanca D., et al.
Publicado: (2009)

Adjuvant chemotherapy
por: Glimelius, B.
Publicado: (2013)

Intravenous versus perineural dexmedetomidine as adjuvant in adductor canal block for total knee arthroplasty
por: Abo-Zeid Salim, Maha Ahmed, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_cu4c1bsrf98ovb0qdnq1eugrd3